SCHEMBL18323136

SCHEMBL18323136

CN1CCN(Cc2ccc(C(=O)Nc3cc(C#N)cc(C#Cc4nnc5cccnn45)c3)cc2C(F)(F)F)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 15/20 0.60
ABL2 P42684 2/20 0.58
KIT P10721 3/20 0.56
RET P07949 3/20 0.56
DDR1 Q08345 2/20 0.56
BCR P11274 2/20 0.56
GAK O14976 1/20 0.56
MLNR O43193 1/20 0.56
RIPK2 O43353 1/20 0.56
JAK2 O60674 1/20 0.56
NR1I2 O75469 1/20 0.56
ABCB11 O95342 1/20 0.56
MAP4K4 O95819 1/20 0.56
EGFR P00533 1/20 0.56
NR3C1 P04150 1/20 0.56
ERBB2 P04626 1/20 0.56
NTRK1 P04629 1/20 0.56
LCK P06239 1/20 0.56
FYN P06241 1/20 0.56
PGR P06401 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15907275 0.94 ABL1 (0.52) ABL1ABL2KITRETDDR1
SCHEMBL18323153 0.86 ABL1 (0.78) ABL1ABL2KITRETDDR1
SCHEMBL18323232 0.85 RET (0.54) ABL1KITRETDDR1EGFR
SCHEMBL15789516 0.84 ABL1 (0.79) ABL1ABL2KITRETDDR1
SCHEMBL18323135 0.84 ABL1 (0.79) ABL1ABL2KITRETDDR1
SCHEMBL18323212 0.83 KIT (0.51) ABL1KITRETDDR1FGFR1
SCHEMBL18323193 0.82 ABL1 (0.58) ABL1ABL2KITRETBCR
SCHEMBL18323147 0.80 KIT (0.66) ABL1KITRETEGFRFGFR1
SCHEMBL15907261 0.80 ABL1 (0.68) ABL1ABL2KITRETDDR1
SCHEMBL18323174 0.80 ABL1 (0.55) ABL1KITRETDDR1EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9522910-B2 Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon Obshchestvo s ogranichennoy otvetstvennostyou “Fusion Pharma” (RU) 2016-12-20 US disclosed
US-9522910-B2 Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon Obshchestvo s ogranichennoy otvetstvennostyou “Fusion Pharma” (RU) 2016-12-20 US disclosed